{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T18:34:01Z","timestamp":1792953241869,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s13555-026-01929-1","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:23:28Z","timestamp":1790925808000},"page":"5687-5700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["D-CARE (Delgocitinib-Chronic hAnd Eczema Response Evaluation): A Retrospective, Multicenter, Real-World Study of Patients with Chronic Hand Eczema (CHE) Treated with Delgocitinib 2% Cream\u2014Temporal Analysis of Symptom and Clinical Sign Response"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3309-8190","authenticated-orcid":false,"given":"Maddalena","family":"Napolitano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Turco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Potestio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Romita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eustachio","family":"Nettis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carla","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mariano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Cristallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Fico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Pigliacelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"di Vico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Fargnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cataldo","family":"Patruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"issue":"6","key":"1929_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/cod.13804","volume":"84","author":"AS Quaade","year":"2021","unstructured":"Quaade AS, Simonsen AB, Halling AS, Thyssen JP, Johansen JD. Prevalence, incidence, and severity of hand eczema in the general population - a systematic review and meta-analysis. Contact Dermatitis. 2021;84(6):361\u201374. https:\/\/doi.org\/10.1111\/cod.13804.","journal-title":"Contact Dermatitis"},{"issue":"10470","key":"1929_CR2","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/S0140-6736(24)01810-5","volume":"404","author":"S Weidinger","year":"2024","unstructured":"Weidinger S, Novak N. Hand eczema. Lancet. 2024;404(10470):2476\u201386. https:\/\/doi.org\/10.1016\/S0140-6736(24)01810-5.","journal-title":"Lancet"},{"key":"1929_CR3","doi-asserted-by":"publisher","first-page":"adv44493","DOI":"10.2340\/actadv.v106.44493","volume":"106","author":"S Molin","year":"2026","unstructured":"Molin S, Fargnoli MC, Crepy MN, et al. Real-world evidence of self-reported treatments, signs, and symptom burden in chronic hand eczema: findings from the multinational CHECK study. Acta Derm Venereol. 2026;106:adv44493. https:\/\/doi.org\/10.2340\/actadv.v106.44493.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"1929_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.5271\/sjweh.3876","volume":"46","author":"T Lund","year":"2020","unstructured":"Lund T, Petersen SB, Flachs EM, Ebbeh\u00f8j NE, Bonde JP, Agner T. Risk of work-related hand eczema in relation to wet work exposure. Scand J Work Environ Health. 2020;46(4):437\u201345. https:\/\/doi.org\/10.5271\/sjweh.3876.","journal-title":"Scand J Work Environ Health"},{"issue":"4","key":"1929_CR5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1600-0536.1989.tb03146.x","volume":"20","author":"EM de Boer","year":"1989","unstructured":"de Boer EM, van Ketel WG, Bruynzeel DP. Dermatoses in metal workers. (II). Allergic contact dermatitis. Contact Dermatitis. 1989;20(4):280\u20136. https:\/\/doi.org\/10.1111\/j.1600-0536.1989.tb03146.x.","journal-title":"Contact Dermatitis"},{"key":"1929_CR6","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v102.360","volume":"102","author":"W Jamil","year":"2022","unstructured":"Jamil W, Svensson \u00c5, Josefson A, Lindberg M, Von Kobyletzki L. Incidence rate of hand eczema in different occupations: a systematic review and meta-analysis. Acta Derm Venereol. 2022;102:adv00681. https:\/\/doi.org\/10.2340\/actadv.v102.360.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"1929_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/cod.14684","volume":"92","author":"L Stingeni","year":"2025","unstructured":"Stingeni L, Napolitano M, Hansel K, et al. Hand eczema in Italian patients referred for patch testing: a retrospective SIDAPA study (2016\u20132023). Contact Dermatitis. 2025;92(1):9\u201320. https:\/\/doi.org\/10.1111\/cod.14684.","journal-title":"Contact Dermatitis"},{"issue":"1","key":"1929_CR8","doi-asserted-by":"publisher","first-page":"2603121","DOI":"10.1080\/09546634.2025.2603121","volume":"37","author":"MC Fargnoli","year":"2026","unstructured":"Fargnoli MC, Molin S, Bewley A, et al. Moderate to severe Chronic Hand Eczema in clinical practice: etiological subtypes, clinical signs and symptoms, and comorbidities-results from the RWEAL study. J Dermatol Treat. 2026;37(1):2603121. https:\/\/doi.org\/10.1080\/09546634.2025.2603121.","journal-title":"J Dermatol Treat"},{"issue":"9","key":"1929_CR9","first-page":"1054","volume":"21","author":"A Bauer","year":"2023","unstructured":"Bauer A, Brans R, Brehler R, et al. S2k guideline diagnosis, prevention, and therapy of hand eczema. JDDG J Dtsch Dermatol Ges. 2023;21(9):1054\u201374.","journal-title":"JDDG J Dtsch Dermatol Ges"},{"issue":"6","key":"1929_CR10","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/cod.70105","volume":"94","author":"R Gallo","year":"2026","unstructured":"Gallo R, Guarneri F, Hansel K, et al. Real-life workup of chronic hand eczema using a dedicated case report form: a SIDAPA multicentre study. Contact Dermatitis. 2026;94(6):662\u201376. https:\/\/doi.org\/10.1111\/cod.70105.","journal-title":"Contact Dermatitis"},{"issue":"2","key":"1929_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/14656566.2021.1998457","volume":"23","author":"M Napolitano","year":"2022","unstructured":"Napolitano M, Potestio L, De Lucia M, Nocerino M, Fabbrocini G, Patruno C. Alitretinoin for the treatment of severe chronic eczema of the hands. Expert Opin Pharmacother. 2022;23(2):159\u201367. https:\/\/doi.org\/10.1080\/14656566.2021.1998457.","journal-title":"Expert Opin Pharmacother"},{"key":"1929_CR12","unstructured":"Delgocitinib cream. Summary of product characteristics. LEO Pharma; September 2024."},{"key":"1929_CR13","unstructured":"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/anzupgo."},{"issue":"10451","key":"1929_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(24)01027-4","volume":"404","author":"R Bissonnette","year":"2024","unstructured":"Bissonnette R, Warren RB, Pinter A, et al. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials. Lancet. 2024;404(10451):461\u201373. https:\/\/doi.org\/10.1016\/S0140-6736(24)01027-4.","journal-title":"Lancet"},{"issue":"2","key":"1929_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.23736\/S2784-8671.24.07733-8","volume":"159","author":"L Stingeni","year":"2023","unstructured":"Stingeni L, Bianchi L, Caroppo ES, et al. The new Italian SIDAPA baseline series for patch testing (2023): an update according to the new regulatory pathway for contact allergens. Ital J Dermatol Venerol. 2023;159(2):83\u2013104. https:\/\/doi.org\/10.23736\/S2784-8671.24.07733-8.","journal-title":"Ital J Dermatol Venerol"},{"issue":"5","key":"1929_CR16","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1007\/s13555-026-01705-1","volume":"16","author":"S Wei\u00dfinger","year":"2026","unstructured":"Wei\u00dfinger S, Oppel E, Kurzen N, et al. A retrospective real-world comparison of topical delgocitinib and localized cream psoralen-ultraviolet A in chronic hand eczema. Dermatol Ther (Heidelb). 2026;16(5):2447\u201363. https:\/\/doi.org\/10.1007\/s13555-026-01705-1.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"1929_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","volume":"171","author":"LK Oetjen","year":"2017","unstructured":"Oetjen LK, Mack MR, Feng J, et al. Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch. Cell. 2017;171(1):217-228.e13. https:\/\/doi.org\/10.1016\/j.cell.2017.08.006.","journal-title":"Cell"},{"issue":"3","key":"1929_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12016-015-8488-5","volume":"51","author":"NK Mollanazar","year":"2016","unstructured":"Mollanazar NK, Smith PK, Yosipovitch G. Mediators of chronic pruritus in atopic dermatitis: getting the itch out? Clin Rev Allergy Immunol. 2016;51(3):263\u201392. https:\/\/doi.org\/10.1007\/s12016-015-8488-5.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1929_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/17103568251408034","author":"C Patruno","year":"2026","unstructured":"Patruno C, Del Gaudio M, Potestio L, Martina E, De Lucia M, Napolitano M. The patient journey: from diagnosis to therapeutic management of chronic hand eczema. Dermatitis. 2026. https:\/\/doi.org\/10.1177\/17103568251408034.","journal-title":"Dermatitis"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01929-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01929-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01929-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T18:00:51Z","timestamp":1792951251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01929-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1929"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01929-1","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"assertion":[{"value":"30 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Maddalena Napolitano acted as consultant, speaker, advisory\u00a0board member, or principal investigator (PI) in clinical trials for: Abbvie, Almirall, Amgen, Eli Lilly, Leo Pharma, Sanofi-Regeneron, Pfizer, Incyte, La Roche, Bionike, and Galderma. Cataldo Patruno acted as consultant, speaker, advisory board member, and\/or investigator for Abbvie, Almirall, Amgen, BioNike, Chiesi, Galderma, La Roche-Posay, Incyte, LeoPharma, Lilly, Novartis, Pfizer, Pierre Fabre, Regeneron, and Sanofi. Maddalena Napolitano is an editorial board member of Dermatology and Therapy. Maddalena Napolitano was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Martina Turco, Luca Potestio, Paolo Romita, Eustachio Nettis, Maria Carla Pisani, Maria Mariano, Mattia Cristallo, Martina Fico, Flavia Pigliacelli, Francesca di Vico, and Maria Concetta Fargnoli have no conflicts of interest to declare. All authors have read and approved the final version of the manuscript.","order":1,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The study was approved by the ethics committee (Comitato Bioetico Universit\u00e0 degli Studi del Molise, protocol no. 6088, 11 February 2026).","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}